Summary. Glutaraldehyde-inactivated cells and cell-wall fractions of Candida albicans were studied for their capacity to induce or inhibit the in-vitro proliferation of human peripheral blood mononuclear cells (PBMC), as measured by 3H-thymidine incorporation. Both the intact cells (CA) and a phosphorylated gluco-mannanprotein complex of the cell wall (GMP), in pg doses, were strong inducers of PBMC proliferation, with a peak of activity at 6-9 days of culture and varying with the PBMC donor. A significant but much lower proliferation was observed on exposure of PBMC to a low-protein (< 3% by weight) mannan component (M) of the cell wall. Both a hot-alkali extracted mannan-protein complex (M-alk), comparable to GMP in crude chemical composition, and an alkali-insoluble cell-wall glucan (GG) were inactive. None of the Candida fractions induced a lymphoproliferation of umbilical cord blood cells and all fractions, except GG, were equally effective in binding human anti-Candida antibodies as shown by a sensitive ELISA-inhibition assay. Moreover, a monoclonal antibody against the class I1 determinant of the HLA complex inhibited PBMC proliferation irrespective of the Candida antigen used. Taken together, the data shows that in inducing lymphoproliferation, Candida fractions act as specific antigens rather than as non-specific mitogens. Use of intact Candida cells and chemically-defined cell-wall components appears preferable to use of undefined antigenic mixtures as stimulators of PBMC proliferation.
Introduction
Most healthy individuals possess significant levels of antibodies against the immunodominant mannan chains of the outer cell wall of Candida albicans (Odds, 1979) . Lymphocyte proliferation in response to Candida extracts, mixtures of undefined antigenic components, are currently used to monitor T-cell dependent immune responses (Brunham et al., 1983; Cox, 1983) .
The ability of Candida preparations to stimulate lymphocyte blastogenesis or specific antibody synthesis or both in vitro has been reported by Piccolella et al. (1980) , Gettner and MacKenzie (198l) , Durandy et al. (1983), De Repentigny and Reiss (1984) and Wirz et al. (1984) . However, either crude antigenic mixtures were used, or no details of the chemical composition and antigenicity of the stimulant fraction were given. Moreover, specific antigenic activation was seldom separated from possible non-specific mitogenic effects. In this study, we report the capacity of purified, chernically-defined mannan-rich components of the cell wall of C. albicans to modulate human lymphocyte proliferation in vitro. Because lymphocyte proliferation in vivo during colonisation or infection by Candida reasonably involves intact cells of the micro-organism as well as the released antigens, we have also compared the proliferative responses elicited by whole microbial cells to those obtained with cell-w all components.
throughout. This strain, identified as described by Lodder (1 970), was routinely maintained on Sabourauddextrose agar at 28 C and, for experimental use, grown with mild agitation in liquid Winge medium (glucose 0 2% w h , yeast extract (BBL. Cockeysville, MD, USA) 0.3%) until stationary-phase growth (48 h) was established. Dense washed-cell suspensions were inactivated with glutaraldehyde (Polysciences, PA, USA) 2% viv in phosphate buffer ( 0 -1 2~, ph 7.2) for 1 h at 37'C, then washed repeatedly with pyrogen-free distilled water for use as whole cells (CA). Yeast-mycelial conversion was induced by suspending 2 x 10' cells!ml in N-acetylglucosaminc medium as reported by Mattia and Cassone ( 1979) . Mycelial growth was stopped after incubation for 370min at 37 C, and hyphal elements ( > 9 5 % ) inactivated and treated as above.
Preparution of' CA-antigenic fractions
A cell-wall fraction (GMP) was obtained by autoclaving washed yeast cells and precipitating the supernate in cold ethanol, according to Sutherland and Wilkinson ( 1971 ) . After deproteination by chloroform-butanol (Sutherland and Wilkinson, 1971) . the aqueous phase uas cxtensivel) dialysed against H,O and then lyophilised. The yield ranged from 0.2 to 0.5% of cell dry weight, and the material consisted essentially of a glucomannan-protein complex (see below). For ELISAinhibition experiments, a similar fraction was prepared from Sachmmyce.i cerevisicre as a control. A mannan fraction (M) was prepared as described by Peat el al. (1961) . M-alk, a mannan-rich preparation was obtained by hot-alkali extraction of acid-treated cell walls, as reported by Korn and Northcote (1960) . An insoluble giucan fraction in the form of "glucan ghosts" (GG) was prepared by cycles of acid and alkali extraction at 100 C as described by Cassone et al. (1978) . This fraction contained about 3% chitin (Cassone et id., 1981) .
CviI separation
Blood samples were obtained from healthy adult volunteers in preservative-free heparin (Eparin Vitrum, Como, Italy) I00 IU/ml. Peripheral blood mononuclear cells (PBMC) were isolated by centrifugation on a density gradient (Lymphoprep, Nyegard, Oslo, Norway) according to Boyum (1968) and washed twice in RPMI medium (Gibco, Grand Island. NY, USA). Cells were then resuspended in RPMI medium supplemented with I O"/O pooled AB serum and antibiotics (penicillin 100 IU/ ml, streptomycin 0.1 mg/m'; Gibco) (complete medium). In some experiments, PBMC from umbilical-cord blood, separated as described above, were used as responder cells.
Pro1 1 jeru t ion ussccl,s
Cultures were set up in flat bottomed 96-microwell trays (Niinc. Denmark). PBMC ( 2 x lo5) were stimulated with CA or its fractions, at the concentrations indicated, in single experiments. All tests were performed in triplicate. Trays were incubated at 37 'C in CO, 5% and the cultures harvested on day 6, unless otherwise stated. Radiolabelled thymidine (meth~l-~H-thyrnidine, 25 Ci/ mMole, I mCi/ml, Amersham, UK) was added to a final concentration of 0-5 pCi/well 18 h before harvesting. Cultures were harvested by a Titertek cell harvester (Skatron, Oslo, Norway) and 3H-thymidine incorporation measured by the two channel ratio, using the external standard method, with a Beckman (Irvine, CA, USA) LS 9100 liquid scintillator system.
In some experiments "commitment" of PBMC proliferation after stimulation with the various C . albicans preparations was evaluated as follows: lo6 PBMC in 1 ml of complete medium were incubated for up to 2 h with an optimal concentration of CA, GMP and M, then extensively washed to remove free antigen and further processed as for the proliferation assay.
Mit ogen -indu ced blas togenesis
Non-specific mitogen-induced blastogenesis was determined by culturing 2 x lo5 PBMC in 0-2ml of complete RPMI medium in flat bottomed 94-microwell trays in the presence of a 1 in 100 dilution of commercial phytohaemagglutinin PHA (HA 15; Wellcome, UK). Pulsing of cultures with 3H-thymidine and isotope-incorporation measurement were performed as described above and the incorporation was stopped on day 3 of PHA stimulation.
Inhibition of CA-induced proliferative response
In a series of experiments, 2 x lo5 PBMC were incubated at 37°C for 1 h with scalar concentrations of soluble mannan fractions from 0.5 to lOOpg/ml. An optimal PBMC-proliferation-inducing amount of CA was then added and the proliferative response evaluated on day 6 as described. In other experiments, a monoclonal antibody (AA 384) against MHC Class-I1 antigen, prepared and characterised as described by Malavasi et al. (I 984) , was added at the time of culture seeding to a final concentration of IOpg/ml. 
Analytical determinations

NMR measurements
31P NMR spectra of Candida antigens were taken at 4°C by means of a Varian FTXL 100-15" spectrometer working at 40*5MHz, interfaced to a 620-L computer under conditions of broad-band proton decoupling. The field: frequency ratio of the spectrometer was stabilised by locking on D,O resonance. Each spectrum represented the Fourier transform of accumulated free induction decay, obtained with a sequence of 60" pulses and acquisition time of 1.50s. The chemical shift was measured in ppm relative to the 85%w/v phosphoric acid as external standard.
Enzyme-linked immunosorbent assay (ELISA)
Assays were performed in polystyrene microtitration plates (Dynatech, Microelisa, CA, USA). Of the antigenic fractions at concentrations of 5 pg/ml, 200~1 were added to wells, held overnight at 4"C, and subsequently rinsed with phosphate-buffered saline (PBS; 0.1 M ,~H 7.4) containing Tween 20 x 3 0.05% v/v. Then 200~1 of hyperimmune human serum (ELISA titre > 128 000) from a candidosis-convalescent donor was added, at the desired dilution, and plates incubated for 1 h at room temperature. After careful washings with Tween 20-PBS buffer, 2 0 0~1 of a 1 in 1000 dilution of goat antihuman IgG-alkaline phosphatase conjugate (Sigma Chemical Co., St Louis, MO, USA) was added for 1 h and enzyme activity was detected by adding nitrophenylphosphate reagent (Sigma). The reaction was terminated by adding 5 0~1 of a 3 M NaOH solution after 20min. In some experiments, ELISA-inhibition tests were performed with cell-wall preparations of C. albicans. Compounds tested as inhibitors were added, at suitable dilutions, to hyperimmune human serum and left overnight at room temperature, then the mixtures were added to antigen-coated wells and the immunosorbent assay performed as described above. The ELISA tests were read with the automated microreader Titertek Multiscan (Skatron, Oslo, Norway), set at 405nm and blanked against air. Tests were performed in triplicate and the OD of the well without a Candida coating antigen was taken as the background reading. A positive test was one with at least twice the absorbance of the background reading and the inhibition was taken as significant only when the mean value of triplicate samples with inhibitor was at least 50% less than the mean value of triplicate samples without inhibitor, at any given serum dilution.
Statistical analysis
(un-paired data).
Statistical analysis was performed by Student's t test 1-3H-thymidine was added 18 h before harvesting the culture.
Thymidine incorporation values were measured on day 3 after addition of PHA or day 6 after addition of CA.
$ 9 Controls for PHA and CA stimulated cultures, respectively.
jl Used at 1 in 100 dilution of a commercial preparation.
Results
Capacity of inactivated cells of C. albicans to stimulate human lymphocyte blastogenesis in vitro
The proliferative response of PBMC to CA was assessed in 25 healthy donors. Table I shows 3H-thymidine incorporation values in a representative experiment with three donors. CA strongly induced lymphoproliferation, optimal responses being recorded in the concentration range 5-50 pg/ml; the response also depended on the specific donor. The PBMC of all donors responded to the nonspecific activator PHA. CA, at concentrations up to 50 pg/ml, did not significantly affect the response to PHA (p > 0.05; data not shown).
The kinetics of the proliferative response induced by CA was also studied. Fig. 1 shows that, with PBMC from a single donor, the optimal proliferative response was detected on day 9 of PBMC culture; the response then declined. With PBMC from a panel of donors, the optimum time of proliferation was in the range 6-9 days. In no case was a proliferative PBMC response observed on day 3 , when the PHA-induced proliferation was usually maximal.
Because C. albicans may grow, either in vitro or in vivo, in two different forms-yeast (Y) or mycelial (M)-and these may express form-specific antigens (Smail and Jones, 1984), we also compared the abilities of Y and M forms to stimulate blastogenesis. PBMC from all the donors responded with a similar efficiency and kinetics to the two growth forms (data not shown). C'hrmicd and untigenic properties 01' cell-wall frac-
tions
Comparative experiments were undertaken with CA and three mannan-rich fractions with the biochemical properties shown in table 11 and fig. 2 . GMP is a cell wall fraction characterised by: (i) relatively high protein content (8% by weight); (ii) mannan as predominant polysaccharide component; and (iii) a high phosphorus; rnannose ratio, as demonstrated both by chemical determination (table I1 I) and by spectrometric P NM R analysis ( fig. 2 ) which showed that phosphorus was present as phosphodiester (a single peak with a chemical shift at around 1.0ppm with respect to an inorganic phosphate standard). The cell-wall component M was mannan with protein c.3% by weight and phosphorus 6% in phosphodiester bonds (data not shown). M-alk consisted of c. 75% polysaccharide with a predominant mannan composition and about 12% protein.
Finally, insoluble glucan, as rigid cell wall skeletons ("glucan ghosts") and essentially devoid of mannan (1.2% by weight) was also examined (table
11).
G M P and M, but not M-alk, acted as solidphase antigens in the detection of human antiCandida antibodies in the ELISA indirect technique. M-alk inhibited the immunosorbent assay with G M P or M as coating antigens, and its inhibitory potency was comparable to that of GMP and M, as shown in fig., 3 . The specificity of this reaction was shown by the absence of inhibition with G M P or M-alk from S. cerevisiae.
Lymphocyte blastogenesis induced by cell-wall fiactions
Stimulation of human lymphocyte blastogenesis by cell-wall fractions is shown in fig. 4 . which shows data from independent experiments with PBMC from two donors. Soluble GMP was most active, with an optimal response in the dose range 50-100pg/ml. Although to a different extent, all the donors tested were as responsive to GMP as they were to CA. M fraction was active but the proliferation was less and much more variable than with GMP. The activities of the soluble fractions performed with PBMC from umbilical-cord blood; the proliferative responses of PBMC to CA and CA-materials were inhibited by monoclonal antibodies directed against HLA-determinants. As shown in table IV, umbilical-cord blood lymphocytes, while optimally responding to PHA, were not stimulated to proliferate by CA or GMP. In other experiments, not shown, the monoclonal antibody A384, directed against a monomorphic determinant, class-IT specific HLA DR molecule (Malavasi et al., 1984) , inhibited the proliferative response of PBMC to all the C. albicans preparations. and CA in the PBMC of all donors are compared in fig. 5 . Induction by GMP and M fractions required contact with PBMC for only 2h to "commit" the responder cells to maximal proliferation as observed in experiments where the PBMC were treated for various periods and then the antigens were washed away and the PBMC were reincubated up to 6 days without any stimulant ( fig. 6) . The M-alk and G G preparations were completely ineffective in stimulating blastogenesis at any concentration up to lOOpg/ml in the PBMC tested ( fig. 4) . Because yeast mannan has been reported to suppress lymphocyte blastogenesis (Fischer et al., 1978; Nelson et al., 1984) we studied the capacity of soluble wall fractions of C. albicans to inhibit CAinduced lymphoproliferation. PBMC were incubated for 1 h at 37°C with the soluble component, then an optimal concentration of CA was added and the culture tested for 3H-thymidine incorporation, in the conditions described. As shown in table 111, M and M-alk significantly inhibited CAinduced lymphoproliferation. PBMC treated with both these fractions remained viable for at least 9 days from the beginning of the treatment with no evidence of toxicity. M and M-alk did not inhibit PHA-induced proliferation.
Supplementary studies on the proliferative response of human PBMC to CA and cell-wall fractions
The experiments reported did not fully discriminate against a possible non-specific mitogenic effect of the preparations. Therefore, experiments were
Discussion
In this study, the in-vitro proliferation of PBMC of normal, healthy individuals in response to chemically-characterised cell-wall fractions of C. albicans has been compared with that induced by whole C. albicans cells (CA). Although CA was the most powerful stimulant of PBMC proliferation, soluble mannan and glucomannan complexes were also active. The insoluble glucan and an alkalidegraded mannan-pro tein complex were devoid of lymphocyte stimulating activity. Mannan components, in addition to PBMC stimulatory activity, were shown to inhibit the lymphoproliferation induced by intact CA.
The soluble mannan fractions GMP and M, which induced significant 1 ymphoproli feration, contained constituents which bind anti-C. albicans antibodies, as shown by the ELISA results with high-titre human serum. Moreover, both fractions specifically inhibited the haemagglutination reaction between the same serum and C . albicansmannan-coated red blood cells (data not shown). This antigenicity, together with the chemical composition, suggests that both GMP and M owe their antigenicity to mannan structures and that their capacity to induce lymphoproliferation is due to antigenic rather than non-specific activation. Evidence for this conclusion came from experiments performed with PBMC from umbilical-cord blood, which showed an optimum response to PHA but no response to C . albicans antigens. Experiments showing the kinetics of 3H-thymidine incorporation (maximum peak at days 6-9 of the culture), the existence of a "commiting" step in the proliferation, and the capacity of a monoclonal antibody directed against a monomorphic determinant of MHC class-IT antigens (Malavasi et al., 1984) to inhibit strongly both CA-and mannan-induced proliferation, present further evidence in support of the above conclusion. The GMP fraction described here was a very active, soluble antigenic stimulator which might correspond to the antigenic activator (MPPS) reported by Piccolella et al. (1980) although these authors reported no details of their preparation. Chemical analysis of GMP showed it to be a glucomannan protein complex with phosphorus present in the form of phosphodiester bonds, as shown by 31P NMR spectra of the compound, and as expected from the nature of the immunodominant mannan chain ( Suzuki and Fukazawa, 1982) .
Although less effective, significant lymphoproliferation was obtained with M, a low-protein rnannan preparation. This mannan was fractionated into several components by DEAE-Sephadex chromatography and it also had a prominent phosphodiester peak in 3 1 P NMR spectrum (data not shown). A failure of low-protein mannan to stimulate lymphocyte blastogenesis or specific antibody synthesis m vitro has been reported by Gettner and MacKenzie Time necessary for the induction of PBMC proliferative response to C. albicans cell-wall fractions (50 pg/ml). The response was assayed after the following treatments: A, medium only for 2 h, wash, culture for 6 days (control); B, M fraction 2 h, wash, culture for 6 days in medium; C , M fraction 2 h, wash, culture for 6 days in M fraction; D, GME! fraction 2 h, wash, medium culture for 6 days in medium; E, GMP fraction 2h, wash, culture for 6 days in GMP fraction. Proliferation was measured on day 6 by the standard 3H-thymidine test. Bars represent f SD. t A 1 in 100 dilution of a commercial preparation.
$ Two independent preparations of the same antigen.
mannan was shown to bind anti-Candida antibodies in the ELISA tests described. We cannot exclude the possibility that a small amount of protein or some undefined component in our preparation could have contributed to our M fraction acting as a blastogenic antigen.
We have shown that all mannan preparations inhibited C. albicans cell-induced lymphoproliferation. Fisher et al. (1982) , working with Candida metabolic antigen as a stimulator and a mannan prepration similar to our M fraction as inhibitor, ascribed the inhibition of blastogenesis to a mannan-mediated interference with antigen presentation by adherent cells. This mechanism could even operate more efficiently when the lymphoproliferative stimulus is given by particulate Candida. However, considering the antigenic nature of the lymphoproliferation induced by GMP and M and the fact that C. albicans has mannan polysaccharide chains on its surface (Cassone et al., 1978; Odds, 1979; Suzuki and Fukazawa, 1982) , the capacity of mannan fractions to inhibit CAinduced lymphocyte blastogenesis could be due to competition for binding to responsive target cells, as also suggested by Nelson et al. (1984) , for the inhibition by Saccharomyces mannan of Candidaantigen stimulated blastogenesis. Other explanations are possible including generation of suppressor cells (Piccolella et al., 1981) . The mechanism of inhibition and its specificity await further studies. Nevertheless, the fact that mannan preparations, even of different composition and structure, may inhibit the proliferative response to Cundidu is a potentially relevant factor in the pathogenesis of candidosis, when consideration is given to the significant amount of mannan antigens secreted by the invading micro-organism in patients affected by systemic candidosis (De Repentigny and Reiss. i 984).
